Literature DB >> 12829406

Neurotoxicological and neuroprotective elements in Parkinson's disease.

Richard M. Kostrzewa1, Juan Segura-Aguilar.   

Abstract

No abstract

Entities:  

Year:  2002        PMID: 12829406     DOI: 10.1080/10298420290015890

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  25 in total

1.  Neuroprotective and neurorestorative strategies for neuronal injury.

Authors:  M F Beal; T Palomo; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

2.  The molecular mechanism of dopamine-induced apoptosis: identification and characterization of genes that mediate dopamine toxicity.

Authors:  A Barzilai; R Zilkha-Falb; D Daily; N Stern; D Offen; I Ziv; E Melamed; A Shirvan
Journal:  J Neural Transm Suppl       Date:  2000

3.  Intracerebral transplantation of testis-derived sertoli cells promotes functional recovery in female rats with 6-hydroxydopamine-induced hemiparkinsonism.

Authors:  C V Borlongan; D F Cameron; S Saporta; P R Sanberg
Journal:  Exp Neurol       Date:  1997-11       Impact factor: 5.330

4.  The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra.

Authors:  B Fornstedt; A Brun; E Rosengren; A Carlsson
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1989

5.  Testis-derived Sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats.

Authors:  P R Sanberg; C V Borlongan; A I Othberg; S Saporta; T B Freeman; D F Cameron
Journal:  Nat Med       Date:  1997-10       Impact factor: 53.440

Review 6.  Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration.

Authors:  W G Tatton; R M Chalmers-Redman
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

7.  Melanin biosynthesis from dopamine. II. A mass spectrometric and collisional spectroscopic investigation.

Authors:  C Costa; A Bertazzo; G Allegri; G Toffano; O Curcuruto; P Traldi
Journal:  Pigment Cell Res       Date:  1992-09

8.  Novel cellular approaches to repair of neurodegenerative disease: from Sertoli cells to umbilical cord blood stem cells.

Authors:  Paul R Sanberg; Alison E Willing; David W Cahill
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

9.  Neurotoxicity of some MAO inhibitors in adult rat hypothalamic cell culture.

Authors:  C Hurtado-Guzmán; P Martínez-Alvarado; A Dagnino-Subiabre; I Paris; P Caviedes; R Caviedes; B K Cassels; J Segura-Aguilar
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

10.  The adrenochrome hypothesis of schizophrenia revisited.

Authors:  John Smythies
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

View more
  4 in total

1.  Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson's disease.

Authors:  Andrea Tamás; Andrea Lubics; István Lengvári; Dóra Reglodi
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

2.  Neuroprotective effect of PACAP on translational control alteration and cognitive decline in MPTP parkinsonian mice.

Authors:  Julie Deguil; François Chavant; Claire Lafay-Chebassier; Marie-Christine Pérault-Pochat; Bernard Fauconneau; Stéphanie Pain
Journal:  Neurotox Res       Date:  2009-07-21       Impact factor: 3.911

3.  MPP(+)-induced degeneration is potentiated by dicoumarol in cultures of the RCSN-3 dopaminergic cell line. Implications of neuromelanin in oxidative metabolism of dopamine neurotoxicity.

Authors:  R Aguilar Hernández; M J Sánchez De Las Matas; C Arriagada; C Barcia; P Caviedes; M T Herrero; J Segura-Aguilar
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 4.  Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases.

Authors:  Eun Hye Lee; Su Ryeon Seo
Journal:  BMB Rep       Date:  2014-07       Impact factor: 4.778

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.